3.65

5.44% -0.21

Sensus Healthcare Inc (SRTS)

Overview News Price History Option Chain Financials Discussions Forecast

Sensus Healthcare Inc stock is currently priced at $3.65, with a 24-hour trading volume of 174.61K. It has seen a -5.44% decreased in the last 24 hours and a +3.11% rose in the past month. The chart indicates a potential bearish trend, as the stock is below the $3.74 pivot point. If it approaches the $3.59 support level, significant changes may occur.

Previous Close:

$3.86

Open:

$3.99

24h Volume:

174.61K

Market Cap:

$59.84M

Revenue:

$24.41M

Net Income/Loss:

$485.00K

P/E Ratio:

26.07

EPS:

0.14

Net Cash Flow:

$-2.37M

1W Performance:

+7.04%

1M Performance:

+3.11%

6M Performance:

+65.91%

1Y Performance:

-25.36%

1D Range:

$3.53

$3.9999

52W Range:

$1.79

$5.38

Sensus Healthcare Inc Stock (SRTS) Company Profile

Name

Sensus Healthcare Inc

Sector

Healthcare (1213)

Industry

Medical Devices (160)

Phone

561-922-5808

Address

851 Broken Sound Parkway NW, Suite 215, Boca Raton, FL

Employee

Twitter

@sensushealth

Next Earnings Date

2024-05-09

Latest SEC Filings

SRTS's Discussions on Twitter

Sensus Healthcare Inc Stock (SRTS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-26-21	Upgrade	Northland Capital	Market Perform → Outperform
Dec-16-20	Downgrade	Northland Capital	Outperform → Market Perform
Aug-10-20	Upgrade	Alliance Global Partners	Neutral → Buy
Feb-14-20	Upgrade	Alliance Global Partners	Neutral → Buy
Nov-07-19	Downgrade	B. Riley FBR	Buy → Neutral
Jan-29-19	Downgrade	Northland Capital	Market Perform → Under Perform
Sep-26-18	Initiated	B. Riley FBR	Buy
Nov-03-17	Reiterated	Maxim Group	Buy
Jun-06-17	Initiated	Maxim Group	Buy
Aug-08-16	Initiated	Northland Capital	Outperform

View All

Sensus Healthcare Inc Stock (SRTS) Latest News

Sensus Healthcare to Host First Quarter 2024 Financial Results and Business Update Conference Call on Thursday, May 9, 2024

GlobeNewswire Inc.

Sensus Healthcare to Participate in the 36th Annual Roth Conference

GlobeNewswire Inc.

Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting

GlobeNewswire Inc.

Sensus Healthcare Inc Stock (SRTS) Financials Data

Sensus Healthcare Inc (SRTS) Revenue 2024

SRTS reported a revenue (TTM) of $24.41 million for the quarter ending December 31, 2023, a -45.19% decline year-over-year.

Sensus Healthcare Inc (SRTS) Net Income 2024

SRTS net income (TTM) was $485.00 thousand for the quarter ending December 31, 2023, a -98.00% decrease year-over-year.

Sensus Healthcare Inc (SRTS) Cash Flow 2024

SRTS recorded a free cash flow (TTM) of -$2.37 million for the quarter ending December 31, 2023, a -51.11% decrease year-over-year.

Sensus Healthcare Inc (SRTS) Earnings per Share 2024

SRTS earnings per share (TTM) was $0.03 for the quarter ending December 31, 2023, a -97.95% decline year-over-year.

Sensus Healthcare, Inc. manufactures and markets superficial radiation therapy devices to healthcare providers worldwide. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides Sentinel service program, which offers its customers protection for their SRT-100 and SRT-100 Vision systems. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons, eye shields, and disposable applicator tips, which are used to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was founded in 2010 and is headquartered in Boca Raton, Florida.